These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31323130)

  • 21. Significance of phrenic nerve electrophysiological abnormalities in Guillain-Barré syndrome.
    Bolton CF
    Neurology; 2006 Jun; 66(12):1961; author reply 1961. PubMed ID: 16801681
    [No Abstract]   [Full Text] [Related]  

  • 22. Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy.
    Onda A; Miyagawa S; Takahashi N; Gochi M; Takagi M; Nishino I; Suzuki S; Oishi C; Yaguchi H
    Intern Med; 2019 Jun; 58(11):1635-1638. PubMed ID: 30713313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute progressive neuropathy-myositis-myasthenia-like syndrome associated with immune-checkpoint inhibitor therapy in patients with metastatic melanoma.
    Möhn N; Sühs KW; Gingele S; Angela Y; Stangel M; Gutzmer R; Satzger I; Skripuletz T
    Melanoma Res; 2019 Aug; 29(4):435-440. PubMed ID: 30855529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse event.
    Lin X; Guan W; Li B; Deng H; Chen Y; Yang Y; Qiu G; Xie X; Zhou C
    Immunopharmacol Immunotoxicol; 2023 Dec; 45(6):780-787. PubMed ID: 37339370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty years of experience in phrenic nerve stimulation to pace the diaphragm.
    Glenn WW; Phelps ML; Elefteriades JA; Dentz B; Hogan JF
    Pacing Clin Electrophysiol; 1986 Nov; 9(6):780-4. PubMed ID: 2432480
    [No Abstract]   [Full Text] [Related]  

  • 26. A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.
    Matsui H; Kawai T; Sato Y; Ishida J; Kadowaki H; Akiyama Y; Yamada Y; Nakamura M; Yamada D; Akazawa H; Suzuki M; Komuro I; Kume H
    Int Heart J; 2020 Sep; 61(5):1070-1074. PubMed ID: 32921673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies.
    Teixeira A; Cherin P; Demoule A; Levy-Soussan M; Straus C; Verin E; Zelter M; Derenne JP; Herson S; Similowski T
    Neuromuscul Disord; 2005 Jan; 15(1):32-9. PubMed ID: 15639118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An autopsy case of nivolumab-induced myasthenia gravis and myositis].
    Sawai T; Hosokawa T; Shigekiyo T; Ogawa S; Sano E; Arawaka S
    Rinsho Shinkeigaku; 2019 Jun; 59(6):360-364. PubMed ID: 31142711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three more immune checkpoint inhibitors for advanced bladder cancer.
    Med Lett Drugs Ther; 2017 Dec; 59(1535):e202-e203. PubMed ID: 29186087
    [No Abstract]   [Full Text] [Related]  

  • 30. Disorders of the Diaphragm.
    McCool FD; Manzoor K; Minami T
    Clin Chest Med; 2018 Jun; 39(2):345-360. PubMed ID: 29779594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phrenic nerve conduction and diaphragmatic motor evoked potentials: evaluation of respiratory dysfunction.
    Lu Z; Tang X; Huang X
    Chin Med J (Engl); 1998 Jun; 111(6):496-9. PubMed ID: 11245065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity and specificity of diagnostic ultrasound in the diagnosis of phrenic neuropathy.
    Boon AJ; Sekiguchi H; Harper CJ; Strommen JA; Ghahfarokhi LS; Watson JC; Sorenson EJ
    Neurology; 2014 Sep; 83(14):1264-70. PubMed ID: 25165390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myositis as an adverse event of immune checkpoint blockade for cancer therapy.
    Shah M; Tayar JH; Abdel-Wahab N; Suarez-Almazor ME
    Semin Arthritis Rheum; 2019 Feb; 48(4):736-740. PubMed ID: 29909921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma.
    Vallet H; Gaillet A; Weiss N; Vanhaecke C; Saheb S; Touitou V; Franck N; Kramkimel N; Borden A; Touat M; Ricard D; Verny M; Maisonobe T; Psimaras D
    Ann Oncol; 2016 Jul; 27(7):1352-3. PubMed ID: 26940685
    [No Abstract]   [Full Text] [Related]  

  • 35. Medical management of pulmonary complications of spinal cord injury.
    Carter RE
    Adv Neurol; 1979; 22():261-9. PubMed ID: 484337
    [No Abstract]   [Full Text] [Related]  

  • 36. Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution.
    Anquetil C; Salem JE; Lebrun-Vignes B; Johnson DB; Mammen AL; Stenzel W; Léonard-Louis S; Benveniste O; Moslehi JJ; Allenbach Y
    Circulation; 2018 Aug; 138(7):743-745. PubMed ID: 30359135
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune checkpoint inhibitor rechallenge in patients with immune-related myositis.
    Delyon J; Brunet-Possenti F; Leonard-Louis S; Arangalage D; Baudet M; Baroudjian B; Lebbe C; Hervier B;
    Ann Rheum Dis; 2019 Nov; 78(11):e129. PubMed ID: 30242031
    [No Abstract]   [Full Text] [Related]  

  • 38. Atezolizumab-induced myositis and myocarditis in a patient with metastatic urothelial carcinoma.
    Sessums M; Yarrarapu S; Guru PK; Sanghavi DK
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33298477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced respiratory failure due to disturbances of diaphragmatic movement.
    Huettemann U; Huckauf H
    Respiration; 1970; 27(4):363-76. PubMed ID: 5428234
    [No Abstract]   [Full Text] [Related]  

  • 40. Laryngeal and phrenic nerve involvement in a patient with hereditary neuropathy with liability to pressure palsies (HNPP).
    Cortese A; Piccolo G; Lozza A; Schreiber A; Callegari I; Moglia A; Alfonsi E; Pareyson D
    Neuromuscul Disord; 2016 Jul; 26(7):455-8. PubMed ID: 27241821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.